|
Limited English Proficiency
|
L01.143.230.750 |
|
|
Communication Barriers
|
L01.143.230 |
|
|
Fenofibrate
|
D02.241.081.114.968.500.625 |
|
|
Vanadium
|
D01.552.544.920 |
|
|
Games, Recreational
|
I03.450.642.693.465 |
|
|
Distance Counseling
|
N02.421.461.363.437 |
|
|
Adenosine Diphosphate Glucose
|
D13.695.827.708.070.075 |
|
|
Adenosine Diphosphate Sugars
|
D13.695.827.708.070 |
|
|
Book Classification
|
L01.453.819.250.150 |
|
|
Dilatation and Curettage
|
E04.950.300.299 |
|
|
Reflex, Vestibulo-Ocular
|
G07.888.937 |
|
|
Thiocapsa roseopersicina
|
B03.440.425.400.750.660 |
|
|
Darbepoetin alfa
|
D000068256 |
[A recombinant protein which stimulates ERYTHROPOIESIS used to treat ANEMIA.
] |
|
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
|
D000068257 |
[Inhibitor of reverse transcriptases or of RNA-directed DNA polymerases.
] |
|
Bevacizumab
|
D000068258 |
[An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS.
] |
|
Aldo-Keto Reductases
|
D08.811.682.047.150.700.156 |
|
|
YY1 Transcription Factor
|
D12.776.260.235.875 |
|
|
Sustainable Growth
|
J01.839 |
|
|
Steroid 17-alpha-Hydroxylase
|
D08.811.682.690.708.170.444.500 |
|
|
Cytochrome P450 Family 17
|
D08.811.682.690.708.170.444 |
|
